Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration

No abstract is available for this paper.

• Publication year

  2003

• Venue

  EMBO Journal

• Publication date

  2003-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/emboj/cdg615PMID 14657026PMCID PMC291810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.

  2003cited by this paper
• Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.

  2003cited by this paper
• Selective E2F‐dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis

  2003cited by this paper
• Caspase‐6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation

  2002cited by this paper
• Amyloid Precursor Protein Family-induced Neuronal Death Is Mediated by Impairment of the Neuroprotective Calcium/Calmodulin Protein Kinase IV-dependent Signaling Pathway*

  2002cited by this paper
• Familial amyotrophic lateral sclerosis

  2002cited by this paper
• Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB.

  2002cited by this paper
• Function and regulation of CREB family transcription factors in the nervous system.

  2002cited by this paper
• Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV.

  2002cited by this paper
• Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway.

  2002cited by this paper
• Caspases on the brain

  2002cited by this paper
• Histone acetylation: a switch between repressive and permissive chromatin

  2002cited by this paper
• Histone modifications and apoptosis: cause or consequence?

  2001cited by this paper
• Histone acetylation and chromatin remodeling.

  2001cited by this paper
• p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

  2001cited by this paper
• CREB-binding Protein and p300 in Transcriptional Regulation*

  2001cited by this paper
• Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

  2001cited by this paper
• SATB1 Cleavage by Caspase 6 Disrupts PDZ Domain-Mediated Dimerization, Causing Detachment from Chromatin Early in T-Cell Apoptosis

  2001cited by this paper
• c‐Jun regulation in rat neonatal motoneurons postaxotomy

  2001cited by this paper
• Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis

  2000cited by this paper
• Acetylation of Histones and Transcription-Related Factors

  2000cited by this paper
• Apoptosis and neurologic disease.

  2000cited by this paper
• Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis

  2000cited by this paper
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

  2000cited by this paper
• Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway.

  2000cited by this paper
• Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway

  1999cited by this paper
• Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis.

  1999cited by this paper
• The Role of Apoptosis in Normal and Abnormal Embryonic Development

  1999cited by this paper
• Regulation of CBP-mediated transcription by neuronal calcium signaling.

  1999cited by this paper
• Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease*

  1999cited by this paper
• Molecular regulation of neuronal apoptosis.

  1998cited by this paper
• Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

  1998cited by this paper
• Visualizing DNA replication in a catalytically active Bacillus DNA polymerase crystal

  1998cited by this paper
• CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV.

  1998cited by this paper
• Roles of histone acetyltransferases and deacetylases in gene regulation

  1998cited by this paper
• FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

  1998cited by this paper
• Signaling to chromatin through histone modifications: how clear is the signal?

  1998cited by this paper
• Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 Å resolution

  1998cited by this paper
• Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase.

  1998cited by this paper
• A top-half tDNA minihelix is a good substrate for the eubacterial CCA-adding enzyme.

  1998cited by this paper
• Biochemical determinants of apoptosis and necrosis.

  1998cited by this paper
• RNA minihelices as model substrates for ATP/CTP:tRNA nucleotidyltransferase.

  1997cited by this paper
• RNA structure: crystal clear?

  1997cited by this paper
• Recovery of soluble, active recombinant protein from inclusion bodies.

  1997cited by this paper
• Proteolytic Cleavage of the mdm2 Oncoprotein during Apoptosis*

  1997cited by this paper
• The anchor site of telomerase from Euplotes aediculatus revealed by photo-cross-linking to single- and double-stranded DNA primers

  1997cited by this paper
• Effects of nucleotide substitutions within the T-loop of precursor tRNAs on interaction with ATP/CTP:tRNA nucleotidyltransferases from Escherichia coli and yeast.

  1996cited by this paper
• The CBP co-activator is a histone acetyltransferase

  1996cited by this paper
• Structure of Taq polymerase with DNA at the polymerase active site

  1996cited by this paper
• Potassium Deprivation-Induced Apoptosis of Cerebellar Granule Neurons: A Sequential Requirement for New mRNA and Protein Synthesis, ICE-Like Protease Activity, and Reactive Oxygen Species

  1996cited by this paper
• Interplay of tRNA-like structures from plant viral RNAs with partners of the translation and replication machineries.

  1996cited by this paper
• CCA-adding enzymes and poly(A) polymerases are all members of the same nucleotidyltransferase superfamily: characterization of the CCA-adding enzyme from the archaeal hyperthermophile Sulfolobus shibatae.

  1996cited by this paper
• Mutational analysis of mammalian poly(A) polymerase identifies a region for primer binding and catalytic domain, homologous to the family X polymerases, and to other nucleotidyltransferases.

  1996cited by this paper
• Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

  1995cited by this paper
• DNA polymerase β belongs to an ancient nucleotidyltransferase superfamily

  1995cited by this paper
• DNA polymerase beta belongs to an ancient nucleotidyltransferase superfamily.

  1995cited by this paper
• Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

  1995cited by this paper
• Interaction of the 3'-end of tRNA with ribonuclease P RNA.

  1994cited by this paper
• The 2.9 A crystal structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser).

  1994cited by this paper
• Minimalist aminoacylated RNAs as efficient substrates for elongation factor Tu.

  1994cited by this paper
• Nuclear protein CBP is a coactivator for the transcription factor CREB

  1994cited by this paper
• NMR analysis of tRNA acceptor stem microhelices: discriminator base change affects tRNA conformation at the 3' end.

  1994cited by this paper
• Yeast tRNAAsp recognition by its cognate class II aminoacyl-tRNA synthetase

  1993cited by this paper
• The 3'-terminal end (NCCA) of tRNA determines the structure and stability of the aminoacyl acceptor stem.

  1993cited by this paper
• Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

  1993cited by this paper
• Phosphorylated CREB binds specifically to the nuclear protein CBP

  1993cited by this paper
• RNA binding determinant in some class I tRNA synthetases identified by alignment-guided mutagenesis.

  1992cited by this paper
• Structural basis of anticodon loop recognition by glutaminyl-tRNA synthetase

  1991cited by this paper
• Cytidines in tRNAs that are required intact by ATP/CTP:tRNA nucleotidyltransferases from Escherichia coli and Saccharomyces cerevisiae.

  1990cited by this paper
• Isolation of a temperature-sensitive mutant with an altered tRNA nucleotidyltransferase and cloning of the gene encoding tRNA nucleotidyltransferase in the yeast Saccharomyces cerevisiae.

  1990cited by this paper
• Enzymatic approaches to probing of RNA secondary and tertiary structure.

  1989cited by this paper
• Recognition of tRNA by the enzyme ATP/CTP:tRNA nucleotidyltransferase. Interference by nucleotides modified with diethyl pyrocarbonate or hydrazine.

  1989cited by this paper
• Telomeric function of the tRNA-like structure of brome mosaic virus RNA.

  1989cited by this paper
• Structure of E. coli glutaminyl-tRNA synthetase complexed with tRNA(Gln) and ATP at 2.8 A resolution.

  1989cited by this paper
• tRNA nucleotidyltransferase is not essential for Escherichia coli viability.

  1987cited by this paper
• Model substrates for an RNA enzyme.

  1987cited by this paper
• tRNA-like structures tag the 3' ends of genomic RNA molecules for replication: implications for the origin of protein synthesis.

  1987cited by this paper
• Yeast tRNAAsp tertiary structure in solution and areas of interaction of the tRNA with aspartyl-tRNA synthetase. A comparative study of the yeast phenylalanine system by phosphate alkylation experiments with ethylnitrosourea.

  1985cited by this paper
• The -C-C-A end of tRNA and its role in protein biosynthesis.

  1985cited by this paper
• Interactions between avian myeloblastosis reverse transcriptase and tRNATrp. Mapping of complexed tRNA with chemicals and nucleases.

  1984cited by this paper
• Tertiary structure of animal tRNATrp in solution and interaction of tRNATrp with tryptophanyl-tRNA synthetase.

  1984cited by this paper
• Effect of elongation factor Tu on the conformation of phenylalanyl‐tRNAPhe

  1983cited by this paper
• Interaction of tRNAPhe and tRNAVal with aminoacyl-tRNA synthetases. A chemical modification study.

  1983cited by this paper
• 7 tRNA Nucleotidyltransferase

  1982cited by this paper
• Tertiary structure of tRNAs in solution monitored by phosphodiester modification with ethylnitrosourea.

  1981cited by this paper
• Dissection of the active site of rabbit liver tRNA nucleotidyltransferase. Specificity and properties of subsites for donor nucleotide triphosphates.

  1980cited by this paper
• Familial amyotrophic lateral sclerosis

  1980cited by this paper
• Dissection of the active site of rabbit liver tRNA nucleotidyltransferase. Specificity and properties of the tRNA and acceptor subsites determined with model acceptor substrates.

  1980cited by this paper

• Microglial histone deacetylase-3 conditional deletion attenuates neurological deficits after intracerebral hemorrhage

  2026cites this paper
• Mapping the hippocampal spatial proteomic signature in male and female mice of an early Alzheimer’s disease model

  2025cites this paper
• Tip60 HAT activators as therapeutic modulators for Alzheimer’s disease

  2025cites this paper
• Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends

  2025cites this paper
• Direct and Indirect Protein Interactions Link FUS Aggregation to Histone Post-Translational Modification Dysregulation and Growth Suppression in an ALS/FTD Yeast Model

  2025cites this paper
• The epigenetic potential of vitamin K2 in brain health

  2025cites this paper
• The Intricate Role of Caspase-6 and Death Receptor-6 in Neurodegenerative Diseases.

  2025cites this paper
• Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future Perspectives.

  2025cites this paper
• Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery

  2025cites this paper
• Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis

  2025cites this paper
• Histone modifications: Key players in Alzheimer's disease.

  2025cites this paper
• HDAC Inhibition Protects RPE Cells from Oxidative Stress via Enhanced Mitochondrial Fusion, Cytoskeletal Repair, and Nrf-2 Activation.

  2025cites this paper
• Histone Modifications as Individual-Specific Epigenetic Regulators: Opportunities for Forensic Genetics and Postmortem Analysis

  2025cites this paper
• Neurodevelopmental functions and activities of the KAT3 class of lysine acetyltransferases.

  2024cites this paper
• ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3

  2024cites this paper
• Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications

  2024cites this paper
• Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis

  2024cites this paper
• From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis.

  2024cites this paper
• Leveraging the redundancy of S-denitrosylases in response to S-nitrosylation of Caspases: experimental strategies and beyond.

  2024cites this paper
• Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect.

  2023cites this paper
• Genomic and transcriptomic advances in amyotrophic lateral sclerosis.

  2023cites this paper
• Global profiling of ribosomal protein acetylation reveals essentiality of acetylation homeostasis in maintaining ribosome assembly and function

  2023cites this paper
• Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS

  2023cites this paper
• The role of altered protein acetylation in neurodegenerative disease

  2023cites this paper
• ATXN3 controls DNA replication and transcription by regulating chromatin structure

  2023cites this paper
• The evolution of small molecule enzyme activators.

  2023cites this paper
• Glucose derived carbon nanosphere (CSP) conjugated TTK21, an activator of the histone acetyltransferases CBP/p300, ameliorates amyloid‐beta 1–42 induced deficits in plasticity and associativity in hippocampal CA1 pyramidal neurons

  2022cites this paper
• Epigenetics in Alzheimer’s Disease

  2022cites this paper
• Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• α-Synuclein upregulates bim-mediated apoptosis by negatively regulating endogenous GCN5

  2022cites this paper
• Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats

  2022cites this paper
• Histone Deacetylase Inhibitors As Cognitive Enhancers And Modifiers Of Mood And Behavior.

  2022cites this paper
• Non-Canonical Roles of Apoptotic Caspases in the Nervous System

  2022cites this paper
• Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase

  2022cites this paper
• TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer’s disease–relevant phenotypes in mice

  2022cites this paper
• Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis

  2021cites this paper
• Autophagy regulation by acetylation—implications for neurodegenerative diseases

  2021cites this paper
• Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

  2021cites this paper
• Age-Related Alterations at Neuromuscular Junction: Role of Oxidative Stress and Epigenetic Modifications

  2021cites this paper
• Roles of the MYST Family in the Pathogenesis of Alzheimer’s Disease via Histone or Non-histone Acetylation

  2021cites this paper
• Outline of epigenetics

  2021cites this paper
• Reduction of Neuroinflammation by δ-Opioids Via STAT3-Dependent Pathway in Chronic Glaucoma Model

  2021cites this paper
• Epigenetics in Drug Discovery: Achievements and Challenges

  2021cites this paper
• Parkinson’s Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning

  2020cites this paper
• Changes in Class I and IIb HDACs by δ-Opioid in Chronic Rat Glaucoma Model

  2020cites this paper
• Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis

  2020cites this paper
• TIP60 in Aging and Neurodegeneration.

  2020cites this paper
• The CBP KIX domain regulates long-term memory and circadian activity

  2020cites this paper
• Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment

  2020cites this paper
• Increased p300/CBP expression in acute respiratory distress syndrome is associated with interleukin‐17 and prognosis

  2020cites this paper
• Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis

  2020cites this paper
• Protective effect of hydrogen sulfide is mediated by negative regulation of epigenetic histone acetylation in Parkinson’s disease

  2020cites this paper
• Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis.

  2020cites this paper
• Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models

  2020cites this paper
• Epigenetics of neuromuscular disorders.

  2020cites this paper
• Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients.

  2020cites this paper
• Inhibition of p300 by Garcinol Protects against Cisplatin-Induced Acute Kidney Injury through Suppression of Oxidative Stress, Inflammation, and Tubular Cell Death in Mice

  2020cites this paper
• The negative role of histone acetylation in cobalt chloride-induced neurodegenerative damages in SHSY5Y cells.

  2020cites this paper
• Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases

  2020cites this paper
• Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.

  2019cites this paper
• HDAC2 Regulates Glial Cell Activation in Ischemic Mouse Retina

  2019cites this paper
• General anesthetic neurotoxicity in the young: Mechanism and prevention.

  2019cites this paper
• Annexin A1 Bioactive Peptide Promotes Resolution of Neuroinflammation in a Rat Model of Exsanguinating Cardiac Arrest Treated by Emergency Preservation and Resuscitation

  2019cites this paper
• Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence

  2019cites this paper
• Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

  2019cites this paper
• Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model

  2019influential citation
• Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic‐based therapies

  2019cites this paper
• Emerging Role of Garcinol in Targeting Cancer Stem Cells of Non-small Cell Lung Cancer

  2019cites this paper
• The dark side of HDAC inhibition in ALS

  2019cites this paper
• In Vivo 6-([18F]Fluoroacetamido)-1-hexanoicanilide PET Imaging of Altered Histone Deacetylase Activity in Chemotherapy-Induced Neurotoxicity

  2018cites this paper
• Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

  2018cites this paper
• Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells.

  2018cites this paper
• Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity

  2018cites this paper
• Restoring Tip60 HAT/HDAC2 Balance in the Neurodegenerative Brain Relieves Epigenetic Transcriptional Repression and Reinstates Cognition

  2018cites this paper
• Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?

  2018cites this paper
• The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease

  2018cites this paper
• Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients

  2018cites this paper
• Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke

  2018cites this paper
• Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.

  2018cites this paper
• Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes.

  2018cites this paper
• Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

  2018influential citation
• HDACIs in the Treatment of Neurodegenerative Diseases

  2018influential citation
• Title A small molecule activator of p300/CBP histone acetyltransferase promotes survival and neurite growth in a cellular model of Parkinson’s disease

  2018cites this paper
• Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model

  2018cites this paper
• Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.

  2017cites this paper
• Neuroprotection against neurodegenerative disorders by histone acetyltransferase inhibitors: An overview

  2017cites this paper
• Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer’s Disease Subjects

  2017cites this paper
• Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim

  2017cites this paper
• Manganese chloride induces histone acetylation changes in neuronal cells: Its role in manganese‐induced damage

  2017cites this paper
• Chapter 25 – Aging Epigenetics

  2017cites this paper
• Alzheimer's Disease and Histone Code Alterations.

  2017influential citation
• Do Histone Acetyltransferase Inhibitors Confer Neuroprotection against Neurodegenerative Disorders ? An Overview

  2017cites this paper
• Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury

  2017cites this paper
• PTEN as a therapeutic target for the promotion of cell survival in cell models of amyotrophic lateral sclerosis

  2017cites this paper
• Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling

  2017cites this paper
• General Anesthesia and Young Brain: What is New?

  2017cites this paper
• Streptococcus pneumoniae R 6 x induced p 38 MAPK and JNK-mediated Caspase-dependent apoptosis in human endothelial cells

  2017cites this paper
• EPIGENETIC MODIFICATIONS TO CYTOSINE AND ALZHEIMER’S DISEASE: A QUANTITATIVE ANALYSIS OF POST-MORTEM TISSUE

  2017cites this paper
• Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines

  2017cites this paper
• Histone Deacetylases as Therapeutic Targets in Neurodegenerative Diseases

  2016cites this paper